On May 5-6, 2023, the 7th Future Medical Top 100 Conference, sponsored by VB100, Artery Network, and Eggshell Research Institute, was held at Zhangjiang Science Hall in Shanghai. At the conference, the "2023 Future Medical Top 100 List" was officially announced.
Huaxin Medical was listed on the "2023 Future Medical Top 100 · China's Top 100 Innovative Medical Devices", and its strength was recognized by the industry!
The Future Medical Top 100 List, founded in 2015, is the first innovative medical field list targeting non listed enterprises in China launched by VB100, Arterial Network, and Eggshell Research Institute. The aim is to select Chinese innovative medical professionals who truly represent future medical care, discover the core strength of China's future medical industry, and promote the innovation and transformation process of the health and medical industry. Over the past seven years, the selection system for the Top 100 Future Healthcare has been continuously enriched, gradually building a global innovative healthcare selection ecosystem for enterprises, investment institutions, and industrial parks, and expanding into the selection of innovative products and technologies.The 7th Future Medical Top 100 Conference in 2023, with the theme of "No Questions about the West and East", interprets the spirit of medical innovation pioneers. The conference officially kicked off on May 5th and released the 2023 Future Healthcare Top 100 list and the "2023 Future Healthcare Top 100 Enterprise Growth Analysis Report" at the Top 100 Awards Ceremony on the evening of May 6th. This conference will conduct an inventory of the four major tracks of medical devices, biopharmaceuticals, digital healthcare, and medical services, committed to discovering new technologies, formats, and models in the field of big health, and jointly promoting the long-term investment layout of the big health industry.2023 Future Healthcare Top 100Main List · China Innovative Medical Device List
This selection is aimed at non listed companies in the medical and health field. The selection is based on the VB100 value evaluation model, and through the process of independent application by enterprises, evaluation by the VB100 evaluation meeting, cross evaluation by supporting institutions, and final review by expert committees, the top 100 innovative enterprises with valuation rankings are selected from five major fields (medical devices/biopharmaceuticals/digital healthcare/medical services/commercial and supply chain services). In addition to valuation, the growth and annual performance of candidate companies in four primary indicators, namely human resources, knowledge resources, important partner resources, and market performance, will be supplemented and examined, with a total of 17 secondary indicator data.
Huaxin Medical specializes in the fields of disposable endoscopes and specialized robots, integrating research and development, production and sales, and service. Its products cover ICU, respiratory, urology, facial features, animal, and industrial fields. The company has subsidiaries in the United States and Germany, as well as research and development centers in Shanghai, Beijing, Wuhan, Changsha, Shenzhen, and other places. It has invested hundreds of millions of yuan to establish a one-time endoscopic full industry chain production line, with a leading automated production system and a quality certification system that complies with global production. More than 60 certifications have been obtained from China's NMPA, the US FDA, the EU CE, as well as Japan and South Korea. The existing product line has covered over 160 major countries and regions worldwide, achieving a global layout。
Return list
Return list
